Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023 DOI Creative Commons
Yiwen Bao, Zeming Mo, Shuang Wang

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Ноя. 15, 2024

Aim and background Tertiary lymphoid structures (TLS) are increasingly recognized for their role in immunity. Despite growing interest, a systematic bibliometric analysis of TLS-related research has been lacking. To provide comprehensive overview current trends hotspots, we conducted using data from the Web Science Core Collection. Methods We retrieved publications Citation Index Expanded within Collection January 2014 to December 2023. Co-occurrence with “VOSviewer” identified status while “CiteSpace” was used co-citation assess knowledge evolution bursts. Thematic explored bibliometrics identify emerging keyword trends. Additionally, examined country/region, institutional, author contributions collaborations. Tables were created Microsoft Word. Results A total 785 analyzed, showing continuous growth trend 2017 2023, indicating escalating interest TLS among researchers. Leading countries China (231 publications), United States (212 France (89 publications). The most productive institution “Institut national de la santé et recherche médicale” (70 publications) Catherine Sautes-Fridman (21 respectively. Key topics included TLS, B cells, immunotherapy. Recent focused on mechanisms linking cancers, such as immunotherapy, tumor microenvironment, tumor-infiltrating lymphocytes, prognosis, immune checkpoint inhibitors, highlighting an expanding area study. TLS’ potential biomarker predicting immunotherapy efficacy across different cancer types remains burgeoning direction. Conclusions This study provides global publications, revealing key literature metrics identifying influential articles concerns. These findings contribute valuable insights into suggest future directions this dynamic field.

Язык: Английский

Tertiary lymphoid structures in anticancer immunity DOI
Jean‐Luc Teillaud, Ana Houel, Marylou Panouillot

и другие.

Nature reviews. Cancer, Год журнала: 2024, Номер 24(9), С. 629 - 646

Опубликована: Авг. 8, 2024

Язык: Английский

Процитировано

43

Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances DOI Creative Commons
Lianyu Zhao,

Song Jin,

Shengyao Wang

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2024, Номер 9(1)

Опубликована: Авг. 28, 2024

Tertiary lymphoid structures (TLSs) are defined as aggregates formed in non-hematopoietic organs under pathological conditions. Similar to secondary (SLOs), the formation of TLSs relies on interaction between tissue inducer (LTi) cells and organizer (LTo) cells, involving multiple cytokines. Heterogeneity is a distinguishing feature TLSs, which may lead differences their functions. Growing evidence suggests that associated with various diseases, such cancers, autoimmune transplant rejection, chronic inflammation, infection, even ageing. However, detailed mechanisms behind these clinical associations not yet fully understood. The by TLS maturation localization affect immune function also unclear. Therefore, it necessary enhance understanding development at cellular molecular level, allow us utilize them improve microenvironment. In this review, we delve into composition, mechanism, potential therapeutic applications TLSs. Furthermore, discuss implications role markers response prognosis. Finally, summarize methods for detecting targeting Overall, provide comprehensive aim develop more effective strategies.

Язык: Английский

Процитировано

18

Role of tertiary lymphoid structures and B cells in clinical immunotherapy of gastric cancer DOI Creative Commons
Wei‐Yi Chen, Lingli Zhang,

Man Gao

и другие.

Frontiers in Immunology, Год журнала: 2025, Номер 15

Опубликована: Янв. 7, 2025

Gastric cancer is a common malignant tumor of the digestive tract, and its treatment remains significant challenge. In recent years, role various immune cells in microenvironment progression has gained increasing attention. Immunotherapy, primarily based on checkpoint inhibitors, notably improved prognosis patients with gastric cancer; however, challenges regarding therapeutic efficacy persist. Histological features within microenvironment, such as tertiary lymphoid structures (TLSs), tumor-infiltrating lymphocytes, proportion intratumoral stroma, are emerging potentially effective prognostic factors. cancer, TLSs may serve local hubs, enhancing ability to interact recognize antigens, which closely linked effectiveness immunotherapy survival rates patients. However, specific cell type driving TLS formation tumors not yet been elucidated. Mature B-cell regions containing germinal centers. During center formation, B undergo transformations become mature function, exerting anti-tumor effects. Therefore, targeting could provide new avenues for immunotherapy. This review, combined current research elaborates relationship between aiming guidance precise

Язык: Английский

Процитировано

5

Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside DOI Creative Commons
Florent Peyraud, Jean‐Philippe Guégan, Lucile Vanhersecke

и другие.

Med, Год журнала: 2025, Номер 6(1), С. 100546 - 100546

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

4

T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle DOI Creative Commons
Wen‐Ping Lin, Hao Li, Zhi‐Jun Sun

и другие.

EBioMedicine, Год журнала: 2024, Номер 104, С. 105154 - 105154

Опубликована: Май 14, 2024

Язык: Английский

Процитировано

10

Emerging strategies to investigate the biology of early cancer DOI
Ran Zhou, Xiwen Tang, Yuan Wang

и другие.

Nature reviews. Cancer, Год журнала: 2024, Номер 24(12), С. 850 - 866

Опубликована: Окт. 21, 2024

Язык: Английский

Процитировано

9

Single-cell spatial transcriptomics of tertiary lymphoid organ-like structures in human atherosclerotic plaques DOI
Zhichao Lai, D. J. Kong, Q L Li

и другие.

Nature Cardiovascular Research, Год журнала: 2025, Номер unknown

Опубликована: Апрель 28, 2025

Язык: Английский

Процитировано

1

A reappraisal of IL-9 in inflammation and cancer DOI Creative Commons
Fabian Bick, Christophe Blanchetot, Bart N. Lambrecht

и другие.

Mucosal Immunology, Год журнала: 2024, Номер unknown

Опубликована: Окт. 1, 2024

Язык: Английский

Процитировано

6

Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy DOI Creative Commons

Xinyu Bao,

Xuwen Lin,

Mei Xie

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Июль 4, 2024

Tertiary lymphoid structures (TLS) represent the ectopic aggregations of immune cells arising during chronic inflammation or tumor progression. In cancer, TLS are often associated with beneficial clinical outcomes in patients undergoing immunotherapy, underscoring their prognostic and predictive significance. Mature TLS, characterized by germinal centers areas T-cell B-cell aggregation, considered primary locations for activating maintaining both humoral cellular anti-tumor effects. Despite recognized importance, mechanisms driving formation mature cancer influence on response within tumors remain insufficiently understood. Therefore, this review aims to comprehensively explore structural composition, development mechanisms, maturity impact factors, immunological function, innovative therapeutic strategies microenvironment. The research summarized herein offers novel insights considerations approaches promote generation maturation representing a promising avenue future therapies.

Язык: Английский

Процитировано

5

From heterogeneity to prognosis: understanding the complexity of tertiary lymphoid structures in tumors DOI
Yingying Wang, Dongyan Zhang, Xueping Huang

и другие.

Molecular Biology Reports, Год журнала: 2025, Номер 52(1)

Опубликована: Фев. 4, 2025

Язык: Английский

Процитировано

0